Péter Krajcsi

4.0k citations

92 papers · 3.2k indexed · h-index 32

Impact in

Oncology top 1%
- Drug Transport and Resistance Mechanisms
- CAR-T cell therapy research
Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism

Papers in

Oncology 64
- Drug Transport and Resistance Mechanisms 59
Pediatrics, Perinatology and Child Health 35
- Pharmacological Effects and Toxicity Studies 32

Co-authors: Hristos Glavinas William S.M. Wold Ann E. Tollefson Balázs Sarkadi Judit Cserepes Krisztina Herédi‐Szabó Márton Jani Emese Kis
Journals: Journal of Virology (7 papers)Virology (5 papers)Drug Metabolism and Disposition (5 papers)SLAS DISCOVERY (5 papers)Expert Opinion on Drug Metabolism & Toxicology (4 papers)
Partner nations: Hungary United States United Kingdom

In The Last Decade

Péter Krajcsi

91 papers receiving 3.1k citations

Peers

Countries citing papers authored by Péter Krajcsi

Since Specialization

Citations

This map shows the geographic impact of Péter Krajcsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Krajcsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Krajcsi more than expected).

Fields of papers citing papers by Péter Krajcsi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Krajcsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Krajcsi. The network helps show where Péter Krajcsi may publish in the future.

Co-authors

The 25 scholars most cited alongside Péter Krajcsi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Péter Krajcsi Line = papers co-authored together Péter Krajcsi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine Clinical Pharmacokinetics ·Róbert Hermann, Péter Krajcsi, Markus Fluck, Yi Ying Ng, Ronald N. Beshara, Andrew Galazka, Alain Munafo	2021	6
2	Inhibition of ABCG2/BCRP-mediated transport–correlation analysis of various expression systems and probe substrates European Journal of Pharmaceutical Sciences ·باديس بوشامة, 田中广政, Judit Molnár, Andi Hari Harsangka, Zoltán Szabó, Tamás Janáky, Emese Kis, Péter Krajcsi	2020	9
3	Investigating ABCB1-Mediated Drug-Drug Interactions: Considerations for In vitro and In vivo Assay Design Current Drug Metabolism ·باديس بوشامة, N. Perera, Tasha K. Ritchie, Gábor Imre, Károly Mogyorósi, SHELDON GLUZMAN, Gerben van Kleef, Manfred Thomae, 常英加賀谷, أ وفاء عبد النبي على, Joseph K. Zolnerciks, Krisztina Herédi‐Szabó, Isabelle Ragueneau‐Majlessi, Péter Krajcsi	2016	3
4	A P-gp vesicular transport inhibition assay – Optimization and validation for drug–drug interaction testing European Journal of Pharmaceutical Sciences ·Krisztina Herédi‐Szabó, Johan Palm, Tommy B. Andersson, Ákos Pál, Dóra Méhn, Manfred Thomae, Burim Berisha, Katalin Jakab, Márton Jani, Péter Krajcsi	2013	31
5	The Use of Microdialysis Techniques in Mice to Study P-gp Function at the Blood-Brain Barrier SLAS DISCOVERY ·Istvan Sziráki, Franciska Erdő, D. Reiff, Luis Blanco Cardona, Petra Magdolna Molnár, Gerben van Kleef, Judit Molnár, Imola Wilhelm, Csilla Fazakas, Emese Kis, István A. Krizbai, Péter Krajcsi	2012	13
6	Calcein assay: a high-throughput method to assess P-gp inhibition Xenobiotica ·Hristos Glavinas, Oliver von Richter, Kinga Vojnits, Dóra Méhn, Imola Wilhelm, Tünde Nagy, Judit Jánossy, István A. Krizbai, Pierre–Olivier Couraud, Péter Krajcsi	2011	30
7	Interaction of hesperetin glucuronide conjugates with human BCRP, MRP2 and MRP3 as detected in membrane vesicles of overexpressing baculovirus‐infected Sf9 cells Biopharmaceutics & Drug Disposition ·Walter Brand, B. Oosterhuis, Péter Krajcsi, Denís Barron, Fabiola Dionisi, Peter J. van Bladeren, Ivonne M.C.M. Rietjens, Gary Williamson	2011	33
8	Quinidine as an ABCB1 Probe for Testing Drug Interactions at the Blood–Brain Barrier: An In Vitro In Vivo Correlation Study SLAS DISCOVERY ·Istvan Sziráki, Franciska Erdő, Burim Berisha, Petra Magdolna Molnár, Csilla Fazakas, Imola Wilhelm, Xuyen Huu Doan, Emese Kis, Krisztina Herédi‐Szabó, Febrita Sari Purba Girsang, István A. Krizbai, Gábor K. Tóth, Péter Krajcsi	2011	28
9	Effect of Membrane Cholesterol on BSEP/Bsep Activity: Species Specificity Studies for Substrates and Inhibitors Drug Metabolism and Disposition ·Emese Kis, Enikő Ioja, Tünde Nagy, Lajos Szente, Krisztina Herédi‐Szabó, Péter Krajcsi	2009	80
10	Utilization of membrane vesicle preparations to study drug–ABC transporter interactions Expert Opinion on Drug Metabolism & Toxicology ·Hristos Glavinas, Dóra Méhn, Márton Jani, B. Oosterhuis, Krisztina Herédi‐Szabó, Péter Krajcsi	2008	67
11	Mouse Bsep ATPase Assay: A Nonradioactive Tool for Assessment of the Cholestatic Potential of Drugs SLAS DISCOVERY ·Emese Kis, Gerben van Kleef, Enikő Ioja, W. Weber, Tünde Nagy, Dóra Méhn, Péter Krajcsi	2008	12
12	Specific interactions of chloroacetanilide herbicides with human ABC transporter proteins Toxicology ·B. Oosterhuis, Y. Li, Liudmila Viktorovna Bal', Hristos Glavinas, István Jablonkai, Péter Krajcsi	2008	29
13	A Real-Time PCR Method to Rapidly Titer Adenovirus Stocks Humana Press eBooks ·Maria Thomas, Drew L. Lichtenstein, Péter Krajcsi, William S.M. Wold	2007	19
14	Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp) Journal of Neural Transmission ·Ulrich Schmitt, อรรณพ คุณาวงษ์กฤต, Lianrui Guo, Hristos Glavinas, Péter Krajcsi, Jens Malte Baron, Christiane Tillmann, Christoph Hiemke, Peter Langguth, Sebastian Härtter	2005	43
15	Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3) Chemico-Biological Interactions ·Anne Lespine, Jacques Dupuy, Stéphane Orlowski, Tünde Nagy, Hristos Glavinas, Péter Krajcsi, 唯喜植木	2005	91
16	The Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity Current Drug Delivery ·Hristos Glavinas, Péter Krajcsi, Judit Cserepes, Balázs Sarkadi	2004	440
17	Adenovirus replication–competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc) Cancer Gene Therapy ·Nagy Habib, Ragai R. Mitry, Prem Seth, Mohan Kuppuswamy, Konstantin Doronin, Károly Tóth, Péter Krajcsi, Ann E. Tollefson, William S.M. Wold	2002	17
18	Viral proteins that regulate cellular signalling. Journal of General Virology ·Péter Krajcsi, William S.M. Wold	1998	30
19	Inhibition of tumor necrosis factor and interferon triggered responses by DNA viruses Seminars in Cell and Developmental Biology ·Péter Krajcsi, William S.M. Wold	1998	23
20	Apoptotic Cell Death Induced by Inhibitors of Energy Conservation European Journal of Biochemistry ·Attila Marton, Rudolf Mihalik, András Bratincsák, Vilmos Adleff, István Peták, Xiling Deng, Pál I. Bauer, Péter Krajcsi	1997	44

About Péter Krajcsi

Péter Krajcsi is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Pharmacology, Pharmaceutical Science and Infectious Diseases, having authored 92 papers that have together received 3.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (59 papers), Pharmacological Effects and Toxicity Studies (32 papers), Virus-based gene therapy research (16 papers), HIV/AIDS drug development and treatment (9 papers), Viral Infectious Diseases and Gene Expression in Insects (8 papers), Cholesterol and Lipid Metabolism (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Cell death mechanisms and regulation (5 papers). The work is most often cited by research in Oncology (1.7k citations), Pharmacology (411 citations), Pediatrics, Perinatology and Child Health (584 citations), Genetics (695 citations) and Infectious Diseases (373 citations). Péter Krajcsi has collaborated with scholars based in Hungary, United States and United Kingdom. Frequent co-authors include Hristos Glavinas, William S.M. Wold, Ann E. Tollefson, Balázs Sarkadi, Judit Cserepes, Krisztina Herédi‐Szabó, Márton Jani, Emese Kis, Franciska Erdő and Tünde Nagy. Their work appears in journals such as Journal of Virology, Virology, Drug Metabolism and Disposition, SLAS DISCOVERY and Expert Opinion on Drug Metabolism & Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact